Total Voting Rights - Replacement

RNS Number : 0177E

GlaxoSmithKline PLC

04 February 2015

 

The headline for the GlaxoSmithKline PLC announcement released on 2 February at 11.49 under RNS No 7679D should read Total Voting Rights.

 

The announcement text is unchanged and is reproduced in full below.

GlaxoSmithKline plc

Total Voting Rights and Capital

In conformity with Disclosure and Transparency Rule 5.6.1R, GlaxoSmithKline plc (the 'Company') hereby notifies the market of the following:

The Company's issued share capital as at 31 January 2015 consisted of 5,355,522,429 Ordinary Shares of 25p each, of which 491,515,950 Ordinary Shares were held in Treasury.

Therefore, the total number of voting rights in the Company is 4,864,006,479. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure and Transparency Rules.

V A Whyte

Company Secretary

2 February 2015

 

END

 

 

TVRPKQDDKBKDPBK